REQUEST A DEMO
Total
USD $0.00
Search more companies

Intec Pharma S.R.O. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Intec Pharma S.R.O. Profile Updated: July 09, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Main activity after establishment in 1990 was development of database software for epidemiology for collecting data about infection diseases. In 1991 company obtained from MoH approval for wholesale of pharmaceutical products, medical devices and diagnostics for stock located in Bratislava. From 1992 the company cooperates with Sero-Merieux (vaccines). In 1993 and 1994 were opened branch offices and stocks in middle and eastern Slovakia, in Zilina and Presov. In 2006 was company certified by ISO 9000:2001 for wholesale of pharmaceutical products, medical devices and diagnostics in cold chain.

Headquarters
Elektrarenska, 4
Bratislava; Bratislavsky; Postal Code: 83104

Contact Details: Purchase the Intec Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Intec Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Intec Pharma S.R.O. report to view the information.
Financial Auditors:
Purchase the Intec Pharma S.R.O. report to view the information.
Incorporation Date:
August 17, 1990
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Intec Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
119.55%
Total operating revenue
97.8%
Operating profit (EBIT)
71.27%
EBITDA
69.95%
Net Profit (Loss) for the Period
29.36%
Total assets
20.43%
Total equity
6.42%
Operating Profit Margin (ROS)
-0.23%
Net Profit Margin
-0.24%
Return on Equity (ROE)
1.07%
Debt to Equity Ratio
-26.29%
Quick Ratio
-0.18%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?